{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:28:45Z","timestamp":1711542525981},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,16]]},"DOI":"10.7759\/cureus.37638","type":"journal-article","created":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T15:09:10Z","timestamp":1681657750000},"source":"Crossref","is-referenced-by-count":1,"title":["Testicular Radiotherapy: A Challenging Irradiation Site"],"prefix":"10.7759","author":[{"given":"Zineb","family":"Dahbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyzane","family":"Elmejjabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Alami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadila","family":"Kouhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers P","year":"2015","unstructured":"Albers P, Albrecht W, Algaba F, et al.. Guidelines on testicular cancer: 2015 update. Eur Urol. 2015, 68:1054-68. 10.1016\/j.eururo.2015.07.044","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00292-022-01121-0","article-title":"Lymphomas and other hematological neoplasms in the testicles [Article in German]","volume":"43","author":"Koch K","year":"2022","unstructured":"Koch K, Oschlies I, Klapper W. Lymphomas and other hematological neoplasms in the testicles [Article in German]. Pathologie (Heidelb). 2022, 43:441-8. 10.1007\/s00292-022-01121-0","journal-title":"Pathologie (Heidelb)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total body irradiation: guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong JY","year":"2018","unstructured":"Wong JY, Filippi AR, Dabaja BS, Yahalom J, Specht L. Total body irradiation: guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys. 2018, 101:521-9. 10.1016\/j.ijrobp.2018.04.071","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.141","article-title":"Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group","volume":"21","author":"Zucca E","year":"2003","unstructured":"Zucca E, Conconi A, Mughal TI, et al.. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003, 21:20-7. 10.1200\/JCO.2003.11.141","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom J","year":"2015","unstructured":"Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, Wirth A. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015, 92:11-31. 10.1016\/j.ijrobp.2015.01.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1146","article-title":"Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial","volume":"17","author":"Foss\u00e5 SD","year":"1999","unstructured":"Foss\u00e5 SD, Horwich A, Russell JM, et al.. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol. 1999, 17:1146. 10.1200\/JCO.1999.17.4.1146","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.003","article-title":"Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)","volume":"23","author":"Jones WG","year":"2005","unstructured":"Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol. 2005, 23:1200-8. 10.1200\/JCO.2005.08.003","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66984-X","article-title":"MRC TE19 collaborators and the EORTC 30982 collaborators. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial","volume":"366","author":"Oliver RT","year":"2005","unstructured":"Oliver RT, Mason MD, Mead GM, et al.. MRC TE19 collaborators and the EORTC 30982 collaborators. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005, 366:293-300. 10.1016\/S0140-6736(05)66984-X","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.01.002","article-title":"Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oldenburg J","year":"2022","unstructured":"Oldenburg J, Berney DM, Bokemeyer C, et al.. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022, 33:362-75. 10.1016\/j.annonc.2022.01.002","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/10428191003793358","article-title":"Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience","volume":"51","author":"Mazloom A","year":"2010","unstructured":"Mazloom A, Fowler N, Medeiros LJ, Iyengar P, Horace P, Dabaja BS. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leuk Lymphoma. 2010, 51:1217-24. 10.3109\/10428191003793358","journal-title":"Leuk Lymphoma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000081319","article-title":"Testicular lymphoma: organ-specific treatment did not improve outcome","volume":"67","author":"Avil\u00e9s A","year":"2004","unstructured":"Avil\u00e9s A, Neri N, Huerta-Guzm\u00e1n J, P\u00e9rez F, Fern\u00e1ndez R. Testicular lymphoma: organ-specific treatment did not improve outcome. Oncology. 2004, 67:211-4. 10.1159\/000081319","journal-title":"Oncology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5139","article-title":"Secondary malignancies in non-Hodgkin lymphoma survivors: 40\u2009years of follow-up assessed by treatment modality","volume":"12","author":"Parsons MW","year":"2023","unstructured":"Parsons MW, Rock C, Chipman JJ, et al.. Secondary malignancies in non-Hodgkin lymphoma survivors: 40\u2009years of follow-up assessed by treatment modality. Cancer Med. 2023, 12:2624-36. 10.1002\/cam4.5139","journal-title":"Cancer Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2010.01.010","article-title":"Normal tissue tolerance to external beam radiation therapy: testicles [Article in French]","volume":"14","author":"Champetier C","year":"2010","unstructured":"Champetier C, Gross E, Pointreau Y, et al.. Normal tissue tolerance to external beam radiation therapy: testicles [Article in French]. Cancer Radiother. 2010, 14:376-8. 10.1016\/j.canrad.2010.01.010","journal-title":"Cancer Radiother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.5296","article-title":"Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer","volume":"25","author":"van den Belt-Dusebout AW","year":"2007","unstructured":"van den Belt-Dusebout AW, de Wit R, Gietema JA, et al.. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2007, 25:4370-8. 10.1200\/JCO.2006.10.5296","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.551","article-title":"Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma","volume":"110","author":"Horwich A","year":"2014","unstructured":"Horwich A, Fossa SD, Huddart R, et al.. Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma. Br J Cancer. 2014, 110:256-63. 10.1038\/bjc.2013.551","journal-title":"Br J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146695-testicular-radiotherapy-a-challenging-irradiation-site","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:29Z","timestamp":1707508769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146695-testicular-radiotherapy-a-challenging-irradiation-site"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,16]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.37638","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,16]]}}}